MSC - Page 14

Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis

Osteoarthritis (OA) is the most common form of arthritis and occurs as a result of the protective cartilage, found on the ends of the bones, degenerates over time. While OA can occur in any joint, it is most commonly found to occur in the hands, hips, spine, and knee. An estimated 365 million people worldwide…

Treating Psoriasis Using Regenerative Medicine

Characterized by scaly white or erythematous plaques, psoriasis is a chronic autoimmune dermatological disease most often appearing on the scalp, genitalia, lumbosacral area, and extensor surfaces of the limbs. Affecting an estimated 125 million people worldwide, the condition most commonly is observed in those between the ages of 15 and 25 years of age. The…

Exploring the Potential of Regenerative Medicine in Addressing the Challenges of Pancreatitis

Acute and chronic pancreatitis are associated with local and systemic inflammation that is linked to a host of serious health issues. A result of the digestive juices and enzymes attacking the pancreas, pancreatitis currently has no definite treatment.  Currently, it is estimated that over 6 million people worldwide are afflicted by acute or chronic pancreatitis…

Using Mesenchymal Regenerative Medicine for Traumatic Spinal Cord Injury

stem cell therapy for spinal cord injury is a global term used to capture damage to the spinal cord resulting from trauma (typically in the form of car accidents, falls, or work-related injuries) or from disease or degenerative conditions.   Worldwide, it is estimated that up to 500,000 people suffer some type of spinal cord injury…

Exploring Cell Therapy for Neuropathic Pain

Neuropathic pain (NP) occurs when the nerves located either inside or outside of the brain and spinal cord are damaged by a lesion or a condition. To date, pharmacological and surgical stem cell therapy for spinal cord injurys to address NP have focused on providing symptomatic relief without treating the underlying cause of the condition. These…

A Systematic Review of Mesenchymal Regenerative Medicine in Multiple Sclerosis

stem cell therapy for multiple sclerosis (MS) is a progressive stem cell therapy for autoimmune conditions that affects the brain, spinal cord, and central nervous system (CNS). Affecting an estimated 3 million people worldwide, MS is typically characterized by an autoimmune response that results in inflammation, demyelination, and degeneration of axons. Most patients who are…

A Systematic Review of Mesenchymal Regenerative Medicine in Traumatic Spinal Cord Injury

stem cell therapy for spinal cord injury (SCI) is a devastating pathological condition affecting motor, sensory, and autonomic function. Additionally, recovery from a traumatic SCI (TSCI) is challenging due to the central nervous system’s limited capacity to regenerate cells, myelin, and neurological connections.  While traditional therapeutic treatments have proven ineffective in assisting in recovery, mesenchymal…

Harnessing Exosomes as Cutting-Edge Drug Delivery Systems for Revolutionary Osteoarthritis Therapy

stem cell therapy for osteoarthritis (OA) is a chronic joint condition that causes pain and lack of mobility through the progressive degradation of joint cartilage. While there are several current pharmaceutical, physical therapy, and surgical treatments to address the symptoms of OA, researchers are interested in developing new therapeutic treatment approaches to address the relentless…

A Comprehensive Review of Mesenchymal Regenerative Medicine in Amyotrophic Lateral Sclerosis (ALS) Patients

Amyotrophic lateral sclerosis (ALS) is a rare, deadly progressive neurological disease that affects the upper and lower motor neurons. Characterized by weakening and gradual atrophy of the voluntary muscles, ALS gradually affects the ability to eat, speak, move, and eventually breathe. With an estimated survival rate of 2 to 5 years from disease onset, 90%…

Assessing The Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stem Cells in Chinese Adults with Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) is a serious health condition characterized by progressive deterioration in glycemic control resulting from decreased insulin sensitivity and diminished insulin secretion. Currently, it is estimated that over 462 million people worldwide are affected by T2DM.  While diet, physical exercise, and glucose-lowering medications have been shown to improve hyperglycemia, the results…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.